World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
84
Citations
28413
World Ranking
1356
National Ranking
697

Medicine

D-Index
85
Citations
28621
World Ranking
14533
National Ranking
7353

Douglas F. Nixon publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Douglas F. Nixon sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 384 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Douglas F. Nixon D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Douglas F. Nixon sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 84 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2014 - Fellow, National Academy of Inventors

Overview

Douglas F. Nixon is affiliated with Cornell University in the United States. Their research spans several interconnected fields, primarily focusing on Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. This work intersects key subfields such as Molecular Biology, Immunology, Infectious Diseases, Virology, and Plant Science.

The scientist's research interests include HIV Research and Treatment, Chromosomal and Genetic Variations, Immune Cell Function and Interaction, as well as SARS-CoV-2 and COVID-19 Research. They have also contributed to studies in COVID-19 Clinical Research and Genomics and Phylogenetic Studies, with a particular emphasis on Cytomegalovirus and herpesvirus research.

Douglas F. Nixon has been actively involved in publishing research papers across a range of high-impact venues. Their frequent publication sources include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Immunology
  • Viruses
  • Journal of Medical Virology
  • JCI Insight

Some of the recent papers authored or co-authored by Nixon are as follows:

  • Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy (2020), Journal of Medical Virology
  • Activation of human endogenous retroviruses and its physiological consequences (2023), Nature Reviews Molecular Cell Biology
  • Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target (2020), Viruses
  • SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements (2021), JCI Insight
  • Locus-Specific Characterization of Human Endogenous Retrovirus Expression in Prostate, Breast, and Colon Cancers (2021), Cancer Research

The scientist has collaborated frequently with several researchers, including:

  • Matthew L. Bendall
  • Jez L. Marston
  • Nicholas Dopkins
  • Rodrigo R. R. Duarte
  • Timothy R. Powell

In recognition of their contributions, Douglas F. Nixon was named a Fellow of the National Academy of Inventors in 2014.

Best Publications

  • Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

    G. S. Ogg;Xia Jin;S. Bonhoeffer;P. R. Dunbar

  • Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.

    R E Phillips;S Rowland-Jones;D F Nixon;F M Gotch

  • HIV-Specific Cd8+T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function

    Victor Appay;Douglas F. Nixon;Sean M. Donahoe;Geraldine M.A. Gillespie

  • Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero

    Jeff E. Mold;Jakob Michaëlsson;Trevor D. Burt;Marcus O. Muench

  • Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

    R. Brad Jones;Lishomwa C Ndhlovu;Jason D. Barbour;Prameet M. Sheth

  • Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

    Sandra Lopez-Vergès;Jeffrey M. Milush;Brian S. Schwartz;Marcelo J. Pando

  • CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset

    Sandra Lopez-Vergès;Jeffrey M. Milush;Suchitra Pandey;Vanessa A. York

  • Human CD4+ CD25+ Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens

    Einar M. Aandahl;Jakob Michaëlsson;Walter J. Moretto;Frederick M. Hecht

  • HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides

    Douglas F. Nixon;Alain R. M. Townsend;John G. Elvin;Charles R. Rizza

  • Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells

    M V Dhodapkar;R M Steinman;M Sapp;H Desai

  • An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants

    Nina F. Rose;Preston A. Marx;Preston A. Marx;Amara Luckay;Douglas F. Nixon

  • Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity

    Lishomwa C. Ndhlovu;Sandra Lopez-Vergès;Jason D. Barbour;R. Brad Jones

  • HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant

    S L Rowland-Jones;D F Nixon;M C Aldhous;F Gotch

  • Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy

    G S Ogg;X Jin;S Bonhoeffer;P Moss

  • Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment

    Brinda Emu;Elizabeth Sinclair;David Favre;Walter J. Moretto

  • HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

    Gabriel M. Ortiz;Douglas F. Nixon;Alexandra Trkola;James Binley

  • Regulation of T cell responses in the developing human fetus.

    Jakob Michaëlsson;Jeff E. Mold;Joseph M. McCune;Douglas F. Nixon

  • Tregs control the development of symptomatic West Nile virus infection in humans and mice

    Marion C. Lanteri;Katie M. O’Brien;Whitney E. Purtha;Mark J. Cameron

  • A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals

    Marie Larsson;Xia Jin;Bharat Ramratnam;Graham S. Ogg

  • The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

    Felipe Garcia;Montserrat Plana;Gabriel M. Ortiz;Sebastian Bonhoeffer

  • Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development

    Edwin Leeansyah;Liyen Loh;Liyen Loh;Douglas F. Nixon;Johan K. Sandberg

  • Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells.

    M Larsson;D Messmer;S Somersan;J F Fonteneau

  • Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells

    Annika C. Karlsson;Jeffrey N. Martin;Sophie R. Younger;Barry M. Bredt

  • Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection.

    Sebastian Bonhoeffer;Michal Rembiszewski;Gabriel M. Ortiz;Douglas F. Nixon

Frequent Co-Authors

Esper G. Kallas
Esper G. Kallas Universidade de São Paulo
Frederick Hecht
Frederick Hecht University of California, San Francisco
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Mario A. Ostrowski
Mario A. Ostrowski University of Toronto
Johan K. Sandberg
Johan K. Sandberg Karolinska University Hospital
Lishomwa C. Ndhlovu
Lishomwa C. Ndhlovu Cornell University
Jeffrey N. Martin
Jeffrey N. Martin University of California, San Francisco
Andrew J. McMichael
Andrew J. McMichael University of Oxford
Andrew Wiznia
Andrew Wiznia Albert Einstein College of Medicine
Jakob Michaëlsson
Jakob Michaëlsson Karolinska University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their immunology knowledge while pursuing a career in healthcare, online degree programs can offer flexible and specialized pathways. Many students start with an online ADN programs for non nurses, which provide foundational nursing skills essential for clinical practice.

Building on that foundation, accelerated NP programs are ideal for individuals looking to fast-track their nursing careers. These programs focus on nurse practitioner specialties, and exploring accelerated NP programs can help identify options suited to your goals in immunology and healthcare.

For nurse practitioners aiming to specialize further, bridging from an FNP to an acute care NP via a FNP to acute care NP bridge program offers a focused curriculum to handle complex patient cases, often linked to immunological conditions.

Understanding potential earnings is also crucial. Reviewing the doctor of nursing practice salary can provide insight into financial prospects across states for advanced practice nurses, helping you make informed career decisions alongside your studies in immunology.

Best Scientists Citing Douglas F. Nixon

Trending Scientists